Literature DB >> 18202751

The HMGA proteins: a myriad of functions (Review).

Isabelle Cleynen1, Wim J M Van de Ven.   

Abstract

The 'high mobility group' HMGA protein family consists of four members: HMGA1a, HMGA1b and HMGA1c, which result from translation of alternative spliced forms of one gene and HMGA2, which is encoded for by another gene. HMGA proteins are characterized by three DNA-binding domains, called AT-hooks, and an acidic carboxy-terminal tail. HMGA proteins are architectural transcription factors that both positively and negatively regulate the transcription of a variety of genes. They do not display direct transcriptional activation capacity, but regulate gene expression by changing the DNA conformation by binding to AT-rich regions in the DNA and/or direct interaction with several transcription factors. In this way, they influence a diverse array of normal biological processes including cell growth, proliferation, differentiation and death. Both HMGA1 and HMGA2 are hardly detectable in normal adult tissue but are abundantly and ubiquitously expressed during embryonic development. In malignant epithelial tumors as well as in leukemia, however, expression of HMGA1 is again strongly elevated to embryonic levels thus leading to ectopic expression of (fetal) target genes. HMGA2 overexpression also has a causal role in inducing neoplasia. Besides overexpression of full length HMGA proteins in different tumors, the HMGA genes are often involved in chromosomal rearrangements. Such translocations are mostly detected in benign tumors of mesenchymal origin and are believed to be one of the most common chromosomal rearrangements in human neoplasia. To provide clarity in the abundance of articles on this topic, this review gives a general overview of the nuclear functions and regulation of the HMGA genes and corresponding proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202751

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  139 in total

1.  Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.

Authors:  Eusebio Chiefari; Stefania Iiritano; Francesco Paonessa; Ilaria Le Pera; Biagio Arcidiacono; Mirella Filocamo; Daniela Foti; Stephen A Liebhaber; Antonio Brunetti
Journal:  Nat Commun       Date:  2010-07-27       Impact factor: 14.919

2.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

3.  Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis.

Authors:  Damian G Romero; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Physiol Genomics       Date:  2010-09-28       Impact factor: 3.107

4.  Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Authors:  Jennifer E Adair; Brian C Beard; Grant D Trobridge; Tobias Neff; Jason K Rockhill; Daniel L Silbergeld; Maciej M Mrugala; Hans-Peter Kiem
Journal:  Sci Transl Med       Date:  2012-05-09       Impact factor: 17.956

5.  A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.

Authors:  Marian Grade; Amanda B Hummon; Jordi Camps; Georg Emons; Melanie Spitzner; Jochen Gaedcke; Patrick Hoermann; Reinhard Ebner; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Tim Beissbarth; Natasha J Caplen; Thomas Ried
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

6.  The Linker Histone GH1-HMGA1 Is Involved in Telomere Stability and DNA Damage Repair.

Authors:  Cyril Charbonnel; Oleh Rymarenko; Olivier Da Ines; Fatiha Benyahya; Charles I White; Falk Butter; Simon Amiard
Journal:  Plant Physiol       Date:  2018-04-05       Impact factor: 8.340

7.  7SK small nuclear RNA transcription level down-regulates in human tumors and stem cells.

Authors:  Mozhgan Abasi; Zahra Bazi; Samira Mohammadi-Yeganeh; Masoud Soleimani; Vahid Haghpanah; Nosratollah Zargami; Hossein Ghanbarian
Journal:  Med Oncol       Date:  2016-10-17       Impact factor: 3.064

8.  Langerhans cell protein 1 (LCP1) binds to PNUTS in the nucleus: implications for this complex in transcriptional regulation.

Authors:  Shin Jeong Lee; Jun Ki Lee; Yong Sun Maeng; Young Myeong Kim; Young Guen Kwon
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

9.  siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

Authors:  Sahar Esmailzadeh; Behzad Mansoori; Ali Mohammadi; Dariush Shanehbandi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2017-06

10.  Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway.

Authors:  Zhizhong Li; Yunyu Zhang; Krishnan Ramanujan; Yan Ma; David G Kirsch; David J Glass
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.